Avantor (NYSE:AVTR) Misses Q4 Sales Targets, Stock Drops
Life sciences company Avantor (NYSE:AVTR) in Q4 CY2024, with sales falling 2.1% year on year to $1.69 billion. Its non-GAAP profit of $0.27 per share was 4.5% above analysts’ consensus estimates. Is now the time to buy Avantor?
Avantor Inc (AVTR) Q4 2024 Earnings Call Highlights: Strong Bioprocessing Growth and Improved ...
Avantor Inc (AVTR) reports high single-digit growth in bioprocessing and a significant increase in adjusted EBITDA margin, despite challenges in the semiconductor market.
Avantor Q4 Earnings Up, Despite Lower Sales; Stock Slides In Pre-market
Avantor, Inc. (AVTR), a biotechnology, chemicals, and pharmaceuticals company, Friday announced a surge in net income for the fourth
Zacks Research Estimates Avantor’s Q1 Earnings (NYSE:AVTR)
Analysts at Zacks Research reduced their Q1 2025 earnings per share estimates for Avantor in a research report issued to clients and investors on Wednesday, February 5th. Zacks Research analyst D. Dey now forecasts that the company will post earnings of $0.
Avantor (AVTR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended December 2024, Avantor, Inc. (AVTR) reported revenue of $1.69 billion, down 2.1% over the same period last year. EPS came in at $0.27, compared to $0.25 in the year-ago quarter.
Avantor reports Q4 earnings beat, revenue miss
NEW YORK - Avantor, Inc. (NYSE:AVTR), a provider of mission-critical products and services to life sciences and advanced technology industries, reported fourth-quarter 2024 results on Friday that beat earnings expectations but fell short on revenue.
Here’s Why Avantor Inc. (AVTR) Crashed on Friday
We recently compiled a list of the 10 Companies Echo Friday’s Market Pessimism. In this article, we are going to take a look ...
StockStory.org on MSN1d
Why Avantor (AVTR) Stock Is Trading Lower Today
What Happened? Shares of life sciences company Avantor (NYSE:AVTR) fell 9.4% in the afternoon session after the company ...
Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025
Avantor's Q4 net sales missed estimates, but adjusted EPS beat expectations. The company projects 2025 organic revenue growth ...
news.stocktradersdaily5d
Learn to Evaluate (AVTR) using the Charts
Check the time stamp on this data. Updated AI-Generated Signals for Avantor Inc. (AVTR) available here: AVTR. Type a few ...
Avantor (AVTR) Receives a Buy from Barclays
In a report released today, Luke Sergott from Barclays maintained a Buy rating on Avantor (AVTR – Research Report), with a price target of ...
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...